Skip to main content
. Author manuscript; available in PMC: 2008 Oct 22.
Published in final edited form as: Vaccine. 2006 Nov 10;25(8):1534–1543. doi: 10.1016/j.vaccine.2006.10.036

Figure 1.

Figure 1

Antibody responses in infected dogs (Group 2) to soluble leishmanianial antigens (SLA) and the P-8 proteoglycolipid complex (P-8 PGLC). Shown are the antibody responses A) IgG1; B) IgG2 and C) Ratio: IgG1/IgG2 of: ▼ — ▼, polysymptomatic; ○— ○, oligosymptomatic; and ●— ● asymptomatic infected dogs at the indicated times post-infection. The antibody responses were examined in 5 asymptomatic, 3 oligosymptomatic and 3 polysymptomatic dogs (P-8) and for 5 asymptomatic, 4 oligosymptomatic and 5 polysymptomatic dogs for SLA antigen.